Robins Kaplan LLP Announces 2020 Executive Board

March 2, 2020

Robins Kaplan LLP today announced the firm’s 2020 Executive Board.

The following partners have been re-elected to two-year board terms:

Jeffrey Gleason and David Martinez, Pro Bono Chair of the Los Angeles office, have been appointed to one-year board terms.

The following partners will continue to serve on the Executive Board:

  • Ronald Schutz, Chair of the Executive Board
  • Steven Schumeister, Managing Partner of the firm
  • Jake Holdreith, Leader, Health and Life Sciences Industry Group
  • Hollis Salzman, Managing Partner of the New York office and Co-Chair of the Antitrust and Trade Regulation Group

Related Publications

Fall 2021
Are All Fiduciaries Created Equal?
Erica Ramsey - The Robins Kaplan Spotlight, Vol. 6, No. 3
Fall 2021
Context Matters: Fiduciaries and the Rule Against Self-Dealing
Brendan Johnson, Tim Billion - The Robins Kaplan Spotlight, Vol. 6, No. 3
Fall 2021
Update on DOL Fiduciary Rule
Michael Reif - The Robins Kaplan Spotlight, Vol. 6, No. 3
September 28, 2021
Briefly: Federal appeals: How much notice is enough?
Stephen Safranski and Geoffrey Kozen - Minnesota Lawyer
Summer 2021
IATL President's Letter on Judicial Security
Roman Silberfeld - The Robins Kaplan Quarterly: Tackling Tough Business Litigation Matters
Back to Top